Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInvestment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShare-based Compensation (IS)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Pharming Group N.V (PHAR) Gross Profit: 2018-2024

Historic Gross Profit for Pharming Group N.V (PHAR) over the last 7 years, with Dec 2024 value amounting to $261.8 million.

  • Pharming Group N.V's Gross Profit rose 32.61% to $90.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $391.2 million, marking a year-over-year increase of 53.14%. This contributed to the annual value of $261.8 million for FY2024, which is 18.94% up from last year.
  • As of FY2024, Pharming Group N.V's Gross Profit stood at $261.8 million, which was up 18.94% from $220.1 million recorded in FY2023.
  • In the past 5 years, Pharming Group N.V's Gross Profit registered a high of $261.8 million during FY2024, and its lowest value of $177.7 million during FY2021.
  • In the last 3 years, Pharming Group N.V's Gross Profit had a median value of $220.1 million in 2023 and averaged $223.3 million.
  • Per our database at Business Quant, Pharming Group N.V's Gross Profit fell by 5.78% in 2021 and then climbed by 18.94% in 2024.
  • Over the past 5 years, Pharming Group N.V's Gross Profit (Yearly) stood at $188.6 million in 2020, then declined by 5.78% to $177.7 million in 2021, then increased by 5.81% to $188.1 million in 2022, then climbed by 17.04% to $220.1 million in 2023, then rose by 18.94% to $261.8 million in 2024.